Benzinga | Nov 2, 2021 04:33PM EDT

Vertex Pharmaceuticals Q3 EPS $3.56 Beats $3.08 Estimate, Sales $1.98B Beat $1.86B Estimate

Vertex Pharmaceuticals (NASDAQ:VRTX) reported quarterly earnings of $3.56 per share which beat the analyst consensus estimate of $3.08 by 15.58 percent. This is a 34.85 percent increase over earnings of $2.64 per share from the same period last year. The company reported quarterly sales of $1.98 billion which beat the analyst consensus estimate of $1.86 billion by 6.67 percent. This is a 29.00 percent increase over sales of $1.54 billion the same period last year.